En lien avec le resvératrol, l'hydroxytyrosine et l'acide alpha-lipoïque 

Acide-αlpha-lipoïque 

• Brufani M, Figliola R. (R)-α-lipoic acid oral liquid formulation: pharmacokinetic parameters and therapeutic efficacy. Acta Biomed. 2014 Aug 20;85(2):108-15. PMID: 25245645. https://pubmed.ncbi.nlm.nih.gov/25245645/
• Abubaker SA, Alonazy AM, Abdulrahman A. Effect of Alpha-Lipoic Acid in the Treatment of Diabetic Neuropathy: A Systematic Review. Cureus. 2022 Jun 8;14(6):e25750. doi: 10.7759/cureus.25750. PMID: 35812639; PMCID: PMC9264721. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264721/pdf/cureus-0014-00000025750.pdf
• Maglione E, Marrese C, Migliaro E, Marcuccio F, Panico C, Salvati C, Citro G, Quercio M, Roncagliolo F, Torello C, Brufani M. Increasing bioavailability of (R)-alpha-lipoic acid to boost antioxidant activity in the treatment of neuropathic pain. Acta Biomed. 2015 Dec 14;86(3):226-33. PMID: 26694149. https://pubmed.ncbi.nlm.nih.gov/26694149/

Resvératrol

• Li YR, Li S, Lin CC. Effect of resveratrol and pterostilbene on aging and longevity. Biofactors. 2018 Jan;44(1):69-82. doi: 10.1002/biof.1400. Epub 2017 Dec 6. PMID: 29210129. https://iubmb.onlinelibrary.wiley.com/doi/10.1002/biof.1400
• Sharma A, Chabloz S, Lapides RA, Roider E, Ewald CY. Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan. Nutrients. 2023 Jan 14;15(2):445. doi: 10.3390/nu15020445. PMID: 36678315; PMCID: PMC9861325. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861325/pdf/nutrients-15-00445.pdf
• Dakik P, McAuley M, Chancharoen M, Mitrofanova D, Lozano Rodriguez ME, Baratang Junio JA, Lutchman V, Cortes B, Simard É, Titorenko VI. Pairwise combinations of chemical compounds that delay yeast chronological aging through different signaling pathways display synergistic effects on the extent of aging delay. Oncotarget. 2019 Jan 8;10(3):313-338. doi: 10.18632/oncotarget.26553. PMID: 30719227; PMCID: PMC6349451. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349451/pdf/oncotarget-10-313.pdf

Hydroxytyrosol

• D'Angelo C, Franceschelli S, Quiles JL, Speranza L. Wide Biological Role of Hydroxytyrosol: Possible Therapeutic and Preventive Properties in Cardiovascular Diseases. Cells. 2020 Aug 21;9(9):1932. doi: 10.3390/cells9091932. PMID: 32825589; PMCID: PMC7565717. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565717/pdf/cells-09-01932.pdf